137 related articles for article (PubMed ID: 16337042)
1. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
Deepa PR; Varalakshmi P
Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042
[TBL] [Abstract][Full Text] [Related]
2. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
[TBL] [Abstract][Full Text] [Related]
3. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
[TBL] [Abstract][Full Text] [Related]
4. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
Deepa PR; Varalakshmi P
Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2004 Jan; 339(1-2):105-15. PubMed ID: 14687900
[TBL] [Abstract][Full Text] [Related]
6. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
Deepa PR; Varalakshmi P
Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
[TBL] [Abstract][Full Text] [Related]
7. Salubrious effect of low molecular weight heparin on atherogenic diet-induced cardiac, hepatic and renal lipid peroxidation and collapse of antioxidant defences.
Deepa PR; Varalakshmi P
Mol Cell Biochem; 2003 Dec; 254(1-2):111-6. PubMed ID: 14674688
[TBL] [Abstract][Full Text] [Related]
8. Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivative.
Kumar SA; Sudhahar V; Varalakshmi P
Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):25-31. PubMed ID: 16737804
[TBL] [Abstract][Full Text] [Related]
9. The effect of aspirin on atherogenic diet-induced diabetes mellitus.
Sethi A; Parmar HS; Kumar A
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):371-7. PubMed ID: 21205219
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental hypercholesterolemia.
Kumar SA; Sudhahar V; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):197-204. PubMed ID: 15820496
[TBL] [Abstract][Full Text] [Related]
11. Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia.
Sudhahar V; Kumar SA; Varalakshmi P
Life Sci; 2006 Feb; 78(12):1329-35. PubMed ID: 16216277
[TBL] [Abstract][Full Text] [Related]
12. Favourable influence of low molecular weight heparin in mitigating the peroxidative membrane damage induced by a cytotoxic agent and an atherogenic diet.
Deepa PR; Varalakshmi P
Hum Exp Toxicol; 2003 May; 22(5):229-35. PubMed ID: 12774884
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of the inflammatory changes and lipid anomalies by epigallocatechin-3-gallate in hypercholesterolemic diet fed aged rats.
Senthil Kumaran V; Arulmathi K; Sundarapandiyan R; Kalaiselvi P
Exp Gerontol; 2009 Dec; 44(12):745-51. PubMed ID: 19732819
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin protection against oxalate-induced oxidative renal insult.
Rajeswari A; Varalakshmi P
Clin Chim Acta; 2006 Aug; 370(1-2):108-14. PubMed ID: 16516183
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2003 Oct; 146(2):201-10. PubMed ID: 14597133
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of grape seed proanthocyanidins against cholesterol cholic acid diet-induced hypercholesterolemia in rats.
Thiruchenduran M; Vijayan NA; Sawaminathan JK; Devaraj SN
Cardiovasc Pathol; 2011; 20(6):361-8. PubMed ID: 21130002
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
Ramesh E; Elanchezhian R; Sakthivel M; Jayakumar T; Senthil Kumar RS; Geraldine P; Thomas PA
Fundam Clin Pharmacol; 2008 Jun; 22(3):275-84. PubMed ID: 18485145
[TBL] [Abstract][Full Text] [Related]
18. Changes in antioxidant defense status in hypercholesterolemic rats treated with Ajuga iva.
Bouderbala S; Lamri-Senhadji M; Prost J; Lacaille-Dubois MA; Bouchenak M
Phytomedicine; 2008 Jun; 15(6-7):453-61. PubMed ID: 18068964
[TBL] [Abstract][Full Text] [Related]
19. Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis.
Kumar SA; Sudhahar V; Varalakshmi P
Atherosclerosis; 2006 Nov; 189(1):115-22. PubMed ID: 16458314
[TBL] [Abstract][Full Text] [Related]
20. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
